Laboratory Financial Statements From 2010 to 2021

LH -  USA Stock  

USD 281.10  2.67  0.94%

Laboratory Corp financial statements provide useful quarterly and yearly information to potential Laboratory Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Laboratory Corp financial statements helps investors assess Laboratory Corp's valuation, profitability, and current liquidity needs.
We have found one hundred twelve available fundamental ratios for Laboratory Corp, which can be analyzed and compared to other ratios and to its peers in the industry. Please verify all of Laboratory Corp last-minute fundamental drivers against the trend between 2010 and 2021 to make sure the company can sustain itself down the road.
The current Working Capital is estimated to increase to about 2.2 B, while Net Income Per Employee is projected to decrease to roughly 18 K.

Search Financial Statements 

 
Refresh
Check Laboratory Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory main balance sheet or income statement drivers, such as Direct Expenses of 9.7 B, Consolidated Income of 1.3 B or Cost of Revenue of 8 B, as well as many exotic indicators such as Interest Coverage of 11.07, Long Term Debt to Equity of 0.83 or Calculated Tax Rate of 33.66. Laboratory financial statements analysis is a perfect complement when working with Laboratory Corp Valuation or Volatility modules. It can also supplement various Laboratory Corp Technical models. Additionally, see the analysis of Laboratory Corp Correlation against competitors.

Laboratory Corp Revenues

12.28 BillionShare

Laboratory Corp Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets17.5 B20.1 B12.5 B
Increasing
Slightly volatile
Cash and Equivalents1.4 B1.3 B568.1 M
Increasing
Slightly volatile
Investments69.6 M73.5 M73.1 M
Decreasing
Slightly volatile
Investments Non Current69.6 M73.5 M73.1 M
Decreasing
Slightly volatile
Deferred Revenue461.2 M506.5 M267.4 M
Increasing
Slightly volatile
Property Plant and Equipment Net2.3 B2.7 B1.5 B
Increasing
Slightly volatile
Inventory335.4 M423.2 M206.3 M
Increasing
Slightly volatile
Tax Assets16.3 M20.6 M11.5 M
Decreasing
Stable
Trade and Non Trade Receivables2.4 BB1.5 B
Increasing
Slightly volatile
Trade and Non Trade Payables590.2 M638.9 M451.2 M
Increasing
Slightly volatile
Goodwill and Intangible Assets10.8 B11.7 B8.2 B
Increasing
Slightly volatile
Total Liabilities9.7 B10.7 B7.3 B
Increasing
Slightly volatile
Shareholders Equity7.8 B9.4 B5.2 B
Increasing
Slightly volatile
Accumulated Retained Earnings DeficitB9.4 B5.4 B
Increasing
Slightly volatile
Accumulated Other Comprehensive Income(174.7 M)(161.9 M)(176.2 M)
Decreasing
Slightly volatile
Current Assets5.5 B5.1 B2.6 B
Increasing
Slightly volatile
Assets Non Current13.5 B14.9 B10.1 B
Increasing
Slightly volatile
Current Liabilities2.6 B3.1 B1.7 B
Increasing
Slightly volatile
Liabilities Non Current7.2 B7.6 B5.6 B
Increasing
Slightly volatile
Tax Liabilities939 M905.4 M810.5 M
Increasing
Slightly volatile
Total Debt6.3 B6.8 B4.9 B
Increasing
Slightly volatile
Debt Current516 M575.4 M380.5 M
Increasing
Slightly volatile
Debt Non Current5.8 B6.2 B4.5 B
Increasing
Slightly volatile
Shareholders Equity USD7.8 B9.4 B5.2 B
Increasing
Slightly volatile
Cash and Equivalents USD1.4 B1.3 B568.1 M
Increasing
Slightly volatile
Total Debt USD6.3 B6.8 B4.9 B
Increasing
Slightly volatile
Accounts Payable524.4 M638.9 M453.2 M
Increasing
Slightly volatile
Receivables2.7 B2.5 B1.3 B
Increasing
Slightly volatile
Inventories456.6 M423.2 M216.4 M
Increasing
Slightly volatile

Laboratory Corp Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues12.3 B14 B8.8 B
Increasing
Slightly volatile
Cost of RevenueBB5.8 B
Increasing
Slightly volatile
Selling General and Administrative Expense1.7 B1.7 B1.4 B
Increasing
Slightly volatile
Operating Expenses2.3 B2.5 B1.7 B
Increasing
Slightly volatile
Interest Expense208.1 M207.4 M174 M
Increasing
Slightly volatile
Income Tax Expense532.9 M662.1 M336.4 M
Increasing
Stable
Consolidated Income1.3 B1.6 B807.6 M
Increasing
Slightly volatile
Net Income to Non Controlling Interests923.7 K900 K3.6 M
Decreasing
Slightly volatile
Net Income1.3 B1.6 B803.9 M
Increasing
Slightly volatile
Net Income Common Stock1.3 B1.6 B803.9 M
Increasing
Slightly volatile
Weighted Average Shares107.5 M97.4 M98 M
Increasing
Slightly volatile
Weighted Average Shares Diluted93.3 M98 M98.7 M
Decreasing
Very volatile
Earning Before Interest and Taxes EBITB2.4 B1.3 B
Increasing
Slightly volatile
Revenues USD12.3 B14 B8.8 B
Increasing
Slightly volatile
Net Income Common Stock USD1.3 B1.6 B803.9 M
Increasing
Slightly volatile
Earning Before Interest and Taxes USDB2.4 B1.3 B
Increasing
Slightly volatile
Gross Profit4.3 BBB
Increasing
Slightly volatile
Operating IncomeB2.4 B1.3 B
Increasing
Slightly volatile
Direct Expenses9.7 BBB
Increasing
Slightly volatile

Laboratory Corp Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Business Acquisitions and Disposals(288.7 M)(267.6 M)(753.1 M)
Increasing
Very volatile
Net Cash Flow Investment Acquisitions and Disposals(40.1 M)(39.1 M)(17.2 M)
Decreasing
Slightly volatile
Net Cash Flow from Financing(531 M)(517.4 M)(36.1 M)
Decreasing
Stable
Issuance Repayment of Debt Securities (423 M)(412.2 M)294.1 M
Decreasing
Stable
Issuance Purchase of Equity Shares(84.8 M)(78.6 M)(308 M)
Increasing
Stable
Net Cash Flow from Investing(694 M)(643.2 M)(1 B)
Decreasing
Very volatile
Net Cash Flow from Operations1.8 B2.1 B1.2 B
Increasing
Slightly volatile
Effect of Exchange Rate Changes on Cash 9.3 M8.6 M(3 M)
Increasing
Stable
Net Cash Flow or Change in Cash and Cash Equivalents1.1 B983.3 M186.1 M
Increasing
Slightly volatile
Share Based Compensation103.2 M111.7 M79 M
Increasing
Slightly volatile
Depreciation Amortization and Accretion685.7 M825 M455.4 M
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share12.9215.998.2084
Increasing
Slightly volatile
Earnings per Diluted Share12.815.888.0975
Increasing
Slightly volatile
Earnings per Basic Share USD12.9215.998.2084
Increasing
Slightly volatile
Return on Average Equity0.180.1950.1761
Decreasing
Slightly volatile
Return on Average Assets0.07410.0840.0713
Decreasing
Slightly volatile
Return on Invested Capital0.220.2350.2295
Decreasing
Slightly volatile
Gross Margin0.330.3540.3464
Decreasing
Slightly volatile
Profit Margin0.09660.1110.0911
Decreasing
Stable
EBITDA Margin0.210.2330.2014
Decreasing
Slightly volatile
Return on Sales0.150.1740.1525
Decreasing
Slightly volatile
Asset Turnover0.720.7560.7655
Decreasing
Slightly volatile
Enterprise Value over EBITDA9.857.959.7956
Increasing
Stable
Enterprise Value over EBIT13.3711.013.114
Increasing
Slightly volatile
Price to Earnings Ratio13.8312.7316.6754
Decreasing
Stable
Sales per Share12614490.2677
Increasing
Slightly volatile
Price to Sales Ratio1.361.4181.4491
Decreasing
Slightly volatile
Price to Book Value2.262.1182.6817
Decreasing
Slightly volatile
Debt to Equity Ratio1.231.1421.4796
Decreasing
Slightly volatile
Current Ratio1.721.6651.4721
Increasing
Stable
Free Cash Flow per Share14.7818.0049.6259
Increasing
Slightly volatile
Book Value per Share79.6596.09552.6705
Increasing
Slightly volatile
Tangible Assets Book Value per Share69.1885.82243.7774
Increasing
Slightly volatile
Total Assets Per Share222206132
Increasing
Slightly volatile
Cash Flow Per Share23.6321.900512.8108
Increasing
Slightly volatile
Return on Investment17.7716.796515.6127
Decreasing
Slightly volatile
Operating Margin17.9417.49415.3164
Decreasing
Slightly volatile
Calculated Tax Rate33.6629.875531.1921
Decreasing
Slightly volatile
Receivables Turnover8.146.92917.7901
Decreasing
Slightly volatile
Inventory Turnover27.3127.027130.7686
Increasing
Very volatile
PPandE Turnover6.955.19567.2507
Decreasing
Slightly volatile
Cash and Equivalents Turnover17.8116.812820.9774
Increasing
Very volatile
Accounts Payable Turnover23.4321.932520.7742
Decreasing
Stable
Accrued Expenses Turnover19.3617.11218.0055
Decreasing
Very volatile
Interest Coverage11.0711.79078.6242
Decreasing
Slightly volatile
Long Term Debt to Equity0.830.5880.8871
Decreasing
Stable
Quick Ratio1.271.23211.1007
Decreasing
Very volatile
Net Current Assets as percentage of Total Assets11.010.19796.1919
Increasing
Slightly volatile
Revenue to Assets0.790.69640.7459
Decreasing
Slightly volatile

Laboratory Corp Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax1.8 B2.2 B1.1 B
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA2.7 B3.3 B1.8 B
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD2.7 B3.3 B1.8 B
Increasing
Slightly volatile
Market Capitalization17.5 B19.8 B12.6 B
Increasing
Slightly volatile
Enterprise Value23.1 B25.8 B17 B
Increasing
Slightly volatile
Invested Capital9.5 B10.7 B6.9 B
Increasing
Slightly volatile
Average Equity6.9 BB4.9 B
Increasing
Slightly volatile
Average Assets16.5 B18.5 B12.1 B
Increasing
Slightly volatile
Invested Capital Average9.3 B10.3 B6.8 B
Increasing
Slightly volatile
Tangible Asset Value6.7 B8.4 B4.3 B
Increasing
Slightly volatile
Free Cash Flow1.4 B1.8 B940.1 M
Increasing
Slightly volatile
Working Capital2.2 BB815.3 M
Increasing
Slightly volatile
Revenue Per Employee175.3 K192.5 K175.7 K
Increasing
Slightly volatile
Net Income Per Employee18 K21.4 K16.1 K
Increasing
Very volatile

Laboratory Fundamental Market Drivers

Forward Price Earnings17.52
Short Percent Of Float1.74%
Average Daily Volume Last 10 Day754.68k
Shares Short Prior Month1.34M
Average Daily Volume In Three Month667.11k
Date Short Interest28th of May 2021
Fifty Day Average270.98
Two Hundred Day Average253.92

Laboratory Upcoming Events

Upcoming Quarterly Report29th of July 2021
Next Earnings Report26th of October 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End10th of February 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

About Laboratory Corp Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Laboratory Corp income statement, its balance sheet, and the statement of cash flows. Laboratory Corp investors use historical funamental indicators, such as Laboratory Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although Laboratory Corp investors may use each financial statement separately, they are all related. The changes in Laboratory Corp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Laboratory Corp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Laboratory Corp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Laboratory Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Deferred Revenue506.5 M461.2 M
Cost of RevenueBB
Revenues14 B12.3 B
Revenue to Assets 0.70  0.79 
Revenue Per Employee192.5 K175.3 K
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development . It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing advanced tests target specific diseases, including anatomic pathologyoncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, womens health, pharmacogenetics, parentage and donor testing and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. In addition, it provides online and mobile applications to enable patients to check test results patient self-service apps and online applications for managed care organizations. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Laboratory Corp Investors Sentiment

The influence of Laboratory Corp's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Laboratory. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - LH

Laboratory Corp Investor Sentiment

Larger part of Macroaxis users are now bullish on Laboratory Corp. What is your trading attitude regarding investing in Laboratory Corp? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Laboratory Corp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see the analysis of Laboratory Corp Correlation against competitors. Note that the Laboratory Corp information on this page should be used as a complementary analysis to other Laboratory Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Laboratory Stock analysis

When running Laboratory Corp price analysis, check to measure Laboratory Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory Corp is operating at the current time. Most of Laboratory Corp's value examination focuses on studying past and present price action to predict the probability of Laboratory Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Laboratory Corp's price. Additionally, you may evaluate how the addition of Laboratory Corp to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
The market value of Laboratory Corp is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory Corp's value that differs from its market value or its book value, called intrinsic value, which is Laboratory Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory Corp's market value can be influenced by many factors that don't directly affect Laboratory Corp underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine Laboratory Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.